Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NexGel, Inc - Warrant (NQ: NXGLW )

0.5185 +0.0485 (+10.32%)
Streaming Delayed Price Updated: 3:49 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,508
Open 0.4700
Bid (Size) 0.0004 (5,185)
Ask (Size) 0.5185 (1)
Prev. Close 0.4700
Today's Range 0.4101 - 0.5185
52wk Range 0.2501 - 1.330
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds
From NEXGEL, INC.
Via GlobeNewswire
NEXGEL Reports Third Quarter 2022 Financial Results
From NEXGEL, INC.
Via GlobeNewswire

Performance

YTD
-30.87%
-30.87%
1 Month
-10.56%
-10.56%
3 Month
-5.73%
-5.73%
6 Month
+3.70%
+3.70%
1 Year
+28.88%
+28.88%

More News

Read More
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
From NEXGEL, INC.
Via GlobeNewswire
NEXGEL Reports Positive Results from Proof-of-Concept Study for its Diclofenac Hydrogel Pain Treatment
From NEXGEL, INC.
Via GlobeNewswire
NEXGEL Develops New Hydrogel Patch to Treat Amblyopia
From NEXGEL, INC.
Via GlobeNewswire
NEXGEL to Participate in Upcoming Investor Conferences in October 2022
From NEXGEL, INC.
Via GlobeNewswire
SAGE Journals Publishes New Data Revealing NEXGEL’s SilverSeal Hydrogel Dressing Improves Postsurgical Scarring
From NEXGEL, INC.
Via GlobeNewswire
NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board
From NEXGEL, INC.
Via GlobeNewswire
NEXGEL Launches MEDAGEL Hydroliner Pro Pads for Eyelash Protection During Cosmetic Extensions Service
From NEXGEL, INC.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.